Követés
Nigel Key
Nigel Key
Harold R Roberts Distinguished Professor of Medicine, University of North Carolina at Chapel Hill
E-mail megerősítve itt: med.unc.edu - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
70151*2014
Guidelines for the management of hemophilia
A Srivastava, AK Brewer, EP Mauser‐Bunschoten, NS Key, S Kitchen, ...
Haemophilia 19 (1), e1-e47, 2013
23732013
Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update
NS Key, AA Khorana, NM Kuderer, K Bohlke, AYY Lee, JI Arcelus, ...
Journal of Clinical Oncology 38 (5), 496-520, 2020
14552020
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
J Cermak, NS Key, RR Bach, J Balla, HS Jacob, GM Vercellotti
13221993
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis
N Mackman, RE Tilley, NS Key
Arteriosclerosis, thrombosis, and vascular biology 27 (8), 1687-1693, 2007
10202007
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update
GH Lyman, AA Khorana, NM Kuderer, AY Lee, JI Arcelus, EP Balaban, ...
Journal of Clinical Oncology 31 (17), 2189-2204, 2013
10032013
D-dimer antigen: current concepts and future prospects
SS Adam, NS Key, CS Greenberg
Blood, The Journal of the American Society of Hematology 113 (13), 2878-2887, 2009
9442009
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014
GH Lyman, K Bohlke, AA Khorana, NM Kuderer, AY Lee, JI Arcelus, ...
Journal of Clinical Oncology 33 (6), 654-656, 2015
9252015
Definitions in hemophilia: communication from the SSC of the ISTH
VS Blanchette, NS Key, LR Ljung, MJ Manco‐Johnson, HM Van Den Berg, ...
Journal of Thrombosis and Haemostasis 12 (11), 1935-1939, 2014
7542014
Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytes
AS Shet, O Aras, K Gupta, MJ Hass, DJ Rausch, N Saba, L Koopmeiners, ...
Blood 102 (7), 2678-2683, 2003
6642003
Blood coagulation: hemostasis and thrombin regulation
KA Tanaka, NS Key, JH Levy
Anesthesia & Analgesia 108 (5), 1433-1446, 2009
4942009
Andrographolide attenuates inflammation by inhibition of NF-κB activation through covalent modification of reduced cysteine 62 of p50
YF Xia, BQ Ye, YD Li, JG Wang, XJ He, X Lin, X Yao, D Ma, A Slungaard, ...
The Journal of Immunology 173 (6), 4207-4217, 2004
4862004
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...
The Lancet Oncology 20 (10), e566-e581, 2019
4762019
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors
NS Key, LM Aledort, D Beardsley, HA Cooper, G Davignon, ...
Thrombosis and haemostasis 80 (12), 912-918, 1998
4481998
Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy
H Bjarnason, JR Kruse, DA Asinger, GK Nazarian, CA Dietz Jr, ...
Journal of Vascular and Interventional Radiology 8 (3), 405-418, 1997
4151997
The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of …
DE Connor, T Exner, DDF Ma, JE Joseph
Thrombosis and haemostasis 103 (05), 1044-1052, 2010
4112010
Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
R Lacroix, C Judicone, M Mooberry, M Boucekine, NS Key, ...
Journal of Thrombosis and Haemostasis 11 (6), 1190-1193, 2013
3912013
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
SW Pipe, M Shima, M Lehle, A Shapiro, S Chebon, K Fukutake, NS Key, ...
The Lancet Haematology 6 (6), e295-e305, 2019
3832019
Induction of microparticle-and cell-associated intravascular tissue factor in human endotoxemia
O Aras, A Shet, RR Bach, JL Hysjulien, A Slungaard, RP Hebbel, ...
Blood 103 (12), 4545-4553, 2004
3812004
Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC …
R Lacroix, S Robert, P Poncelet, RS Kasthuri, NS Key, F Dignat‐George
Journal of Thrombosis and Haemostasis 8 (11), 2571-2574, 2010
3662010
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20